NMRC clears Fabu-Paracetamol following safety concerns

Allexer Namundjembo

The Namibia Medicines Regulatory Council (NMRC) has confirmed that Fabu-Paracetamol meets required safety and quality standards following an independent assessment prompted by public concerns.

In a public notice dated 20 May 2026, former Registrar of Medicines Fransina Nambahu said the NMRC commissioned independent laboratory testing on samples collected from various health facilities, including Central Medical Stores, to ensure a representative evaluation of the product available on the market.

“A comprehensive number of batches were sampled and subjected to analytical testing. The results indicate that all batches complied with the required quality specifications and contained the correct quantities of active pharmaceutical ingredient (API) and preservative,” the notice read.